0
April 18, 1986, Vol 255, No. 15 >
ARTICLE | April 18, 1986

Leads from the MMWR FREE

JAMA. 1986;255(15):1990-1993. doi:10.1001/jama.1986.03370150028005
Text Size: A A A
Published online
Article
References

REFERENCES

1 +
ACIP:  Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease . MMWR 1985;;34:201-205.
2 +
Band JD, Fraser DW, Ajello G:  Prevention of Haemophilus influenzae type b disease . JAMA 1984;;251:2381-2386.
3 +
Ward JI, Fraser DW, Baraff LJ, Plikaytis BD:  Haemophilus influenzae meningitis. A national study of secondary spread in household contacts . N Engl J Med 1979;;301:122-126.
4 +
Glode MP, Daum RS, Goldmann DA, Leclair J, Smith A:  Haemophilus influenzae type b meningitis: A contagious disease of children . Br Med J 1980;;280:899-901.
5 +
Filice GA, Andrews JS Jr, Hudgins MP, Fraser DW:  Spread of Haemophilus influenzae. Secondary illness in household contacts of patients with H influenzae meningitis . Am J Dis Child 1978;;132:757-759.
6 +
Granoff DM, Basden M:  Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease . J Infect Dis 1980;;141:40-46.
7 +
Campbell LR, Zedd AJ, Michaels RH:  Household spread of infection due to Haemophilus influenzae type b . Pediatrics 1980;;66:115-117.
8 +
Fleming DW, Leibenhaut MH, Albanes D, et al:  Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention . JAMA 1985;;254:509-514.
9 +
Murphy TV, Clements JF, Hansen EJ:  Subsequent disease risk in day care facilities with a primary case of H influenzae b disease . Twenty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. 1985 ;214 (abstract #668).
10 +
Osterholm MT, Pierson LM, White KE, Libby TA, Kuritsky JN:  The risk of subsequent transmission of Haemophilus influenzae type b disease in day care: Results of a statewide surveillance system and contact survey . Twenty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. 1985 ;214 (abstract #667).
11 +
Gessert C, Granoff DM, Gilsdorf J:  Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease . Pediatrics 1980;;66:1-4.
12 +
Shapiro ED, Wald ER:  Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b . Pediatrics 1980;;66:5-8.
13 +
Cox F, Trincher R, Rissing JP, McCracken GH Jr, Granoff DM:  Rifampin prophylaxis for contacts of Haemophilus influenzae type b . JAMA 1981;;245:1043-1045.
14 +
Murphy TV, McCracken GH Jr, Moore BS, Gulig PA, Hansen EJ:  Haemophilus influenzae type b disease after rifampin prophylaxis in a day care center: possible reasons for its failure . Pediatr Infect Dis 1983;;2:193-198.
15 +
McCracken GH Jr, Ginsburg CM, Zweighaft TC, Clahsen J:  Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type b disease . Pediatrics 1980;;66:17-21.
16 +
Wahdan MH, Sallam SA, Hassan MN, et al:  A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria . Bull WHO 1977;;55:645-651.
17 +
Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C:  Prevention of meningococcal disease by group C polysaccharide vaccine . N Engl J Med 1970;;282:417-420.
18 +
Greenwood BM, Hassan-King M, Whittle HC:  Prevention of secondary cases of meningococcal disease in household contacts by vaccination . Br Med J 1987;;1:1317-1319.
19 +
Kayhty H, Jousimies-Somer H, Peltola H, Makela PH:  Antibody response to capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease . J Infect Dis 1981;;143:32-41.
20 +
O'Reilly RJ, Anderson P, Ingram DL, Peter G, Smith DH:  Circulating polyribophosphate in Hemophilus influenzae type b meningitis. Correlation with clinical course and antibody response . J Clin Invest 1975;;56:1012-1022.
21 +
Kayhty H, Karanko V, Peltola H, Makela PH:  Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory . Pediatrics 1984;;74:857-865.
22 +
Peterson DR:  Evolution of the epidemiology of sudden infant death syndrome . Epidemiologic Rev 1980;;2:97-112.
23 +
Adams MM:  The descriptive epidemiology of sudden infant deaths among natives and whites in Alaska . Am J Epidemiol 1985;; 122:637-643.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

1 +
ACIP:  Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease . MMWR 1985;;34:201-205.
2 +
Band JD, Fraser DW, Ajello G:  Prevention of Haemophilus influenzae type b disease . JAMA 1984;;251:2381-2386.
3 +
Ward JI, Fraser DW, Baraff LJ, Plikaytis BD:  Haemophilus influenzae meningitis. A national study of secondary spread in household contacts . N Engl J Med 1979;;301:122-126.
4 +
Glode MP, Daum RS, Goldmann DA, Leclair J, Smith A:  Haemophilus influenzae type b meningitis: A contagious disease of children . Br Med J 1980;;280:899-901.
5 +
Filice GA, Andrews JS Jr, Hudgins MP, Fraser DW:  Spread of Haemophilus influenzae. Secondary illness in household contacts of patients with H influenzae meningitis . Am J Dis Child 1978;;132:757-759.
6 +
Granoff DM, Basden M:  Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease . J Infect Dis 1980;;141:40-46.
7 +
Campbell LR, Zedd AJ, Michaels RH:  Household spread of infection due to Haemophilus influenzae type b . Pediatrics 1980;;66:115-117.
8 +
Fleming DW, Leibenhaut MH, Albanes D, et al:  Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention . JAMA 1985;;254:509-514.
9 +
Murphy TV, Clements JF, Hansen EJ:  Subsequent disease risk in day care facilities with a primary case of H influenzae b disease . Twenty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. 1985 ;214 (abstract #668).
10 +
Osterholm MT, Pierson LM, White KE, Libby TA, Kuritsky JN:  The risk of subsequent transmission of Haemophilus influenzae type b disease in day care: Results of a statewide surveillance system and contact survey . Twenty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. 1985 ;214 (abstract #667).
11 +
Gessert C, Granoff DM, Gilsdorf J:  Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease . Pediatrics 1980;;66:1-4.
12 +
Shapiro ED, Wald ER:  Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b . Pediatrics 1980;;66:5-8.
13 +
Cox F, Trincher R, Rissing JP, McCracken GH Jr, Granoff DM:  Rifampin prophylaxis for contacts of Haemophilus influenzae type b . JAMA 1981;;245:1043-1045.
14 +
Murphy TV, McCracken GH Jr, Moore BS, Gulig PA, Hansen EJ:  Haemophilus influenzae type b disease after rifampin prophylaxis in a day care center: possible reasons for its failure . Pediatr Infect Dis 1983;;2:193-198.
15 +
McCracken GH Jr, Ginsburg CM, Zweighaft TC, Clahsen J:  Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type b disease . Pediatrics 1980;;66:17-21.
16 +
Wahdan MH, Sallam SA, Hassan MN, et al:  A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria . Bull WHO 1977;;55:645-651.
17 +
Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C:  Prevention of meningococcal disease by group C polysaccharide vaccine . N Engl J Med 1970;;282:417-420.
18 +
Greenwood BM, Hassan-King M, Whittle HC:  Prevention of secondary cases of meningococcal disease in household contacts by vaccination . Br Med J 1987;;1:1317-1319.
19 +
Kayhty H, Jousimies-Somer H, Peltola H, Makela PH:  Antibody response to capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease . J Infect Dis 1981;;143:32-41.
20 +
O'Reilly RJ, Anderson P, Ingram DL, Peter G, Smith DH:  Circulating polyribophosphate in Hemophilus influenzae type b meningitis. Correlation with clinical course and antibody response . J Clin Invest 1975;;56:1012-1022.
21 +
Kayhty H, Karanko V, Peltola H, Makela PH:  Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory . Pediatrics 1984;;74:857-865.
22 +
Peterson DR:  Evolution of the epidemiology of sudden infant death syndrome . Epidemiologic Rev 1980;;2:97-112.
23 +
Adams MM:  The descriptive epidemiology of sudden infant deaths among natives and whites in Alaska . Am J Epidemiol 1985;; 122:637-643.

Letters

Submit a Letter
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems